nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

28.09.2018 | Original Article – Cancer Research

Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway

verfasst von: Dolores Fernández, Macarena Guereño, María Amparo Lago Huvelle, Magalí Cercato, María Giselle Peters

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We have shown that GPC3 overexpression in breast cancer cells inhibits in vivo tumor progression, by acting as a metastatic suppressor. GPC3-overexpressing cells are less clonogenic, viable and motile, while their homotypic adhesion is increased. We have presented evidences indicating that GPC3 inhibits canonical Wnt and Akt pathways, while non-canonical Wnt and p38MAPK cascades are activated. In this study, we aimed to investigate whether GPC3-induced Wnt signaling inhibition modulates breast cancer cell properties as well as to describe the interactions among pathways modulated by GPC3.

Methods

Fluorescence microscopy, qRT-PCR microarray, gene reporter assay and Western blotting were performed to determine gene expression levels, signaling pathway activities and molecule localization. Lithium was employed to activate canonical Wnt pathway and treated LM3-GPC3 cell viability, migration, cytoskeleton organization and homotypic adhesion were assessed using MTS, wound healing, phalloidin staining and suspension growth assays, respectively.

Results

We provide new data demonstrating that GPC3 blocks—also at a transcriptional level—both autocrine and paracrine canonical Wnt activities, and that this inhibition is required for GPC3 to modulate migration and homotypic adhesion. Our results indicate that GPC3 is secreted into the extracellular media, suggesting that secreted GPC3 competes with Wnt factors or interacts with them and thus prevents Wnt binding to Fz receptors. We also describe the complex network of interactions among GPC3-modulated signaling pathways.

Conclusion

GPC3 is operating through an intricate molecular signaling network. From the balance of these interactions, the inhibition of breast metastatic spread induced by GPC3 emerges.

Nur mit Berechtigung zugänglich

Akiyama T, Kamimura K, Firkus C, Takeo S, Shimmi O, Nakato H (2008) Dally regulates Dpp morphogen gradient formation by stabilizing Dpp on the cell surface. Dev Biol 313:408–419CrossRefPubMed

Amin N, Vincan E (2012) The Wnt signaling pathways and cell adhesion. Front Biosci (Landmark Ed) 17:784–804CrossRef

Baeg GH, Perrimon N (2000) Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila. Curr Opin Cell Biol 12:575–580CrossRefPubMed

Baeg GH, Lin X, Khare N, Baumgartner S, Perrimon N (2001) Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless. Development 128:87–94PubMed

Bafico A, Liu G, Goldin L, Harris V, Aaronson SA (2004) An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6:497–506. https://doi.org/10.1016/j.ccr.2004.09.032 CrossRefPubMed

Banerjee S, Gordon L, Donn TM, Berti C, Moens CB, Burden SJ, Granato M (2011) A novel role for MuSK and non-canonical Wnt signaling during segmental neural crest cell migration. Development 138:3287–3296. https://doi.org/10.1242/dev.067306 CrossRefPubMedPubMedCentral

Benhaj K, Akcali KC, Ozturk M (2006) Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncol Rep 15:701–707PubMed

Bikkavilli RK, Feigin ME, Malbon CC (2008a) G alpha o mediates WNT-JNK signaling through dishevelled 1 and 3, RhoA family members, and MEKK 1 and 4 in mammalian cells. J Cell Sci 121:234–245. https://doi.org/10.1242/jcs.021964 CrossRefPubMed

Bikkavilli RK, Feigin ME, Malbon CC (2008b) p38 mitogen-activated protein kinase regulates canonical Wnt-beta-catenin signaling by inactivation of GSK3beta. J Cell Sci 121:3598–3607. https://doi.org/10.1242/jcs.032854 CrossRefPubMed

Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254CrossRefPubMed

Buchanan C et al (2010) Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways. Breast Cancer Res Treat 119:559–574. https://doi.org/10.1007/s10549-009-0362-9 CrossRefPubMed

Buchanan C, Lago Huvelle MA, Peters MG (2011) Metastasis suppressors: basic and translational advances. Curr Pharm Biotechnol 12:1948–1960CrossRefPubMed

Cai K, Jiang L, Wang J, Zhang H, Wang X, Cheng D, Dou J (2014) Downregulation of beta-catenin decreases the tumorigenicity, but promotes epithelial-mesenchymal transition in breast cancer cells. J Cancer Res Ther 10:1063–1070. https://doi.org/10.4103/0973-1482.139378 CrossRefPubMed

Cano-Gauci DF et al (1999) Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson–Golabi–Behmel syndrome. J Cell Biol 146:255–264PubMedPubMedCentral

Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, Filmus J (2003) Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology 125:89–97CrossRefPubMed

Capurro MI, Xiang YY, Lobe C, Filmus J (2005) Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical. Wnt Signaling Cancer Res 65:6245–6254CrossRefPubMed

Capurro MI, Xu P, Shi W, Li F, Jia A, Filmus J (2008) Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding. Dev Cell 14:700–711. https://doi.org/10.1016/j.devcel.2008.03.006 CrossRefPubMed

Capurro M, Martin T, Shi W, Filmus J (2014) Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling. J Cell Sci 127:1565–1575. https://doi.org/10.1242/jcs.140871 CrossRefPubMed

Castillo L et al (2015) Expression of Glypican-3 (GPC3) in malignant and non-malignant human breast tissues. Open Cancer J 8:12–23. https://doi.org/10.2174/1874079001508010012 CrossRef

Castillo LF et al (2016) Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells. Oncotarget. https://doi.org/10.18632/oncotarget.11107 CrossRefPubMedPubMedCentral

Chang J et al (2007) Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem 282:30938–30948. https://doi.org/10.1074/jbc.M702391200 CrossRefPubMed

Desbordes SC, Sanson B (2003) The glypican Dally-like is required for Hedgehog signalling in the embryonic epidermis of Drosophila. Development 130:6245–6255CrossRefPubMed

Dihlmann S, Klein S, Doeberitz Mv M (2003) Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin. Mol Cancer Ther 2:509–516PubMed

Dwivedi PP, Grose RH, Filmus J, Hii CS, Xian CJ, Anderson PJ, Powell BC (2013) Regulation of bone morphogenetic protein signalling and cranial osteogenesis by Gpc1 and Gpc3. Bone 55:367–376. https://doi.org/10.1016/j.bone.2013.04.013 CrossRefPubMed

Fang D et al (2007) Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem 282:11221–11229. https://doi.org/10.1074/jbc.M611871200 CrossRefPubMed

Feng M, Kim H, Phung Y, Ho M (2011) Recombinant soluble glypican 3 protein inhibits the growth of hepatocellular carcinoma in vitro. Int J Cancer 128:2246–2247. https://doi.org/10.1002/ijc.25549 CrossRefPubMedPubMedCentral

Filmus J, Shi W, Wong ZM, Wong MJ (1995) Identification of a new membrane-bound heparan sulphate proteoglycan. Biochem J 311(Pt 2):561–565CrossRefPubMedCentralPubMed

Force T, Woulfe K, Koch WJ, Kerkela R (2007) Molecular scaffolds regulate bidirectional crosstalk between Wnt and classical seven-transmembrane-domain receptor signaling pathways. Sci STKE Signal Transduct Knowl Environ 2007:pe41. https://doi.org/10.1126/stke.3972007pe41 CrossRef

Gottardi CJ, Gumbiner BM (2004) Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol 167:339–349. https://doi.org/10.1083/jcb.200402153 CrossRefPubMedPubMedCentral

Gutierrez J, Brandan E (2010) A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts allowing skeletal muscle differentiation. Mol Cell Biol 30:1634–1649. https://doi.org/10.1128/MCB.01164-09 CrossRefPubMedPubMedCentral

Han C, Yan D, Belenkaya TY, Lin X (2005) Drosophila glypicans Dally and Dally-like shape the extracellular Wingless morphogen gradient in the wing disk. Development 132:667–679CrossRefPubMed

Han S et al (2016) Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer. Oncotarget 7:44406–44416. https://doi.org/10.18632/oncotarget.9763 CrossRefPubMedPubMedCentral

Hankey W, Frankel WL, Groden J (2018) Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer Metastasis Rev 37:159–172. https://doi.org/10.1007/s10555-017-9725-6 CrossRefPubMedPubMedCentral

Hartsock A, Nelson WJ (2008) Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochimica et Biophysica Acta 1778:660–669. https://doi.org/10.1016/j.bbamem.2007.07.012 CrossRefPubMed

Hippo Y et al (2004) Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res 64:2418–2423CrossRefPubMed

Iglesias BV et al (2008) Expression pattern of glypican-3 (GPC3) during human embryonic and fetal development. Histol Histopathol 23:1333–1340PubMed

Ishitani T et al (1999) The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor. TCF Nat 399:798–802. https://doi.org/10.1038/21674 CrossRef

Ishitani T et al (2003) The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca(2+) pathway to antagonize Wnt/beta-catenin signaling. Mol Cell Biol 23:131–139CrossRefPubMedCentralPubMed

Khare N, Baumgartner S (2000) Dally-like protein, a new Drosophila glypican with expression overlapping with wingless. Mech Dev 99:199–202CrossRefPubMed

Kim AH, Khursigara G, Sun X, Franke TF, Chao MV (2001) Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol 21:893–901. https://doi.org/10.1128/MCB.21.3.893-901.2001 CrossRefPubMedPubMedCentral

Kim H et al (2003) The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. Am J Respir Cell Mol Biol 29:694–701. https://doi.org/10.1165/rcmb.2003-0061OC CrossRefPubMed

Kim JH et al (2010) Beta-catenin regulates melanocyte dendricity through the modulation of PKCzeta and PKCdelta. Pigment Cell Melanoma Res 23:385–393. https://doi.org/10.1111/j.1755-148X.2010.00695.x CrossRefPubMed

Klein PS, Melton DA (1996) A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93:8455–8459CrossRefPubMedCentralPubMed

Kreuger J, Perez L, Giraldez AJ, Cohen SM (2004) Opposing activities of Dally-like glypican at high and low levels of Wingless morphogen activity. Dev Cell 7:503–512CrossRefPubMed

Krishnamurthy N, Kurzrock R (2018) Targeting the Wnt/beta-catenin pathway in cancer: update on effectors and inhibitors. Cancer Treat Rev 62:50–60. https://doi.org/10.1016/j.ctrv.2017.11.002 CrossRefPubMed

Li G et al (2018) Frizzled7 promotes epithelial-to-mesenchymal transition and stemness via activating canonical Wnt/beta-catenin pathway in gastric cancer. Int J Biol Sci 14:280–293. https://doi.org/10.7150/ijbs.23756 CrossRefPubMedPubMedCentral

Lin H, Huber R, Schlessinger D, Morin PJ (1999) Frequent silencing of the GPC3 gene in ovarian cancer cell lines. Cancer Res 59:807–810PubMed

Lin CL, Wang JY, Huang YT, Kuo YH, Surendran K, Wang FS (2006) Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J Am Soc Nephrol 17:2812–2820. https://doi.org/10.1681/ASN.2005121355 CrossRefPubMed

Ma L, Wang HY (2007) Mitogen-activated protein kinase p38 regulates the Wnt/cyclic GMP/Ca²⁺ non-canonical pathway. J Biol Chem 282:28980–28990. https://doi.org/10.1074/jbc.M702840200 CrossRefPubMed

Ma J et al (2010) IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. J Surg Res 160:90–101. https://doi.org/10.1016/j.jss.2008.08.016 CrossRefPubMed

Maeda D, Ota S, Takazawa Y, Aburatani H, Nakagawa S, Yano T, Taketani Y, Kodama T, Fukayama M (2009) Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod Pathol 22:824–832. https://doi.org/10.1038/modpathol.2009.40 CrossRefPubMed

Maguire PB, Donlon T, Parsons M, Wynne K, Dillon E, Ni Ainle F, Szklanna PB (2018) Proteomic analysis reveals a strong association of beta-catenin with cadherin adherens junctions in resting. Hum Platelets Proteom 18:e1700419. https://doi.org/10.1002/pmic.201700419 CrossRef

Mitsiades CS, Mitsiades N, Koutsilieris M (2004) The Akt pathway: molecular targets for anti-cancer drug development. Curr Cancer Drug Targets 4:235–256CrossRefPubMed

Mizushima S, Nagata S (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18:5322CrossRefPubMedCentralPubMed

Montalbano M, Rastellini C, McGuire JT, Prajapati J, Shirafkan A, Vento R, Cicalese L (2018) Role of Glypican-3 in the growth, migration and invasion of primary hepatocytes isolated from patients with hepatocellular carcinoma. Cell Oncol (Dordr) 41:169–184. https://doi.org/10.1007/s13402-017-0364-2 CrossRef

Murthy SS et al (2000) Expression of GPC3, an X-linked recessive overgrowth gene is silenced in malignant mesothelioma. Oncogene 19:410–416. https://doi.org/10.1038/sj.onc.1203322 CrossRefPubMed

Pellegrini M et al (1998) Gpc3 expression correlates with the phenotype of the Simpson–Golabi–Behmel syndrome. Dev Dyn 213:431–439CrossRefPubMed

Peters MG, Farias E, Colombo L, Filmus J, Puricelli L, Bal de Kier Joffe E (2003) Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model. Breast Cancer Res Treat 80:221–232CrossRefPubMed

Pilia G et al (1996) Mutations in GPC3, a glypican gene, cause the Simpson–Golabi–Behmel overgrowth syndrome. Nat Genet 12:241–247CrossRefPubMed

Princivalle M, de Agostini A (2002) Developmental roles of heparan sulfate proteoglycans: a comparative review in Drosophila, mouse and human. Int J Dev Biol 46:267–278PubMed

Roarty K, Pfefferle AD, Creighton CJ, Perou CM, Rosen JM (2017) Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression. Oncogene 36:5958–5968. https://doi.org/10.1038/onc.2017.206 CrossRefPubMedPubMedCentral

Rosso SB, Sussman D, Wynshaw-Boris A, Salinas PC (2005) Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat Neurosci 8:34–42. https://doi.org/10.1038/nn1374 CrossRefPubMed

Saad K, Theis S, Otto A, Luke G, Patel K (2017) Detailed expression profile of the six Glypicans and their modifying enzyme, Notum during chick limb feather development. Gene 610:71–79. https://doi.org/10.1016/j.gene.2017.02.012 CrossRefPubMed

Sakane H, Yamamoto H, Matsumoto S, Sato A, Kikuchi A (2012) Localization of glypican-4 in different membrane microdomains is involved in the regulation of Wnt signaling. J Cell Sci 125:449–460. https://doi.org/10.1242/jcs.091876 CrossRefPubMed

Sharma M, Castro-Piedras I, Simmons GE Jr, Pruitt K (2018) Dishevelled: a masterful conductor of complex Wnt signals. Cell Signal 47:52–64. https://doi.org/10.1016/j.cellsig.2018.03.004 CrossRefPubMedPubMedCentral

Song HH, Shi W, Xiang YY, Filmus J (2005) The loss of glypican-3 induces alterations in Wnt signaling. J Biol Chem 280:2116–2125CrossRefPubMed

Stigliano I, Puricelli L, Filmus J, Sogayar MC, Bal de Kier Joffe E, Peters MG (2009) Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation. Breast Cancer Res Treat 114:251–262. https://doi.org/10.1007/s10549-008-0009-2 CrossRefPubMed

Sugimura J et al (2004) Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis. Clin Cancer Res Off J Am Assoc Cancer Res 10:2368–2378CrossRef

Sun TQ, Lu B, Feng JJ, Reinhard C, Jan YN, Fantl WJ, Williams LT (2001) PAR-1 is a Dishevelled-associated kinase and a positive regulator of Wnt signalling. Nat Cell Biol 3:628–636. https://doi.org/10.1038/35083016 CrossRefPubMed

Tangkijvanich P, Chanmee T, Komtong S, Mahachai V, Wisedopas N, Pothacharoen P, Kongtawelert P (2010) Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers. J Gastroenterol Hepatol 25:129–137. https://doi.org/10.1111/j.1440-1746.2009.05988.x CrossRefPubMed

Toretsky JA et al (2001) Glypican-3 expression in Wilms tumor and hepatoblastoma. J Pediatr Hematol Oncol 23:496–499CrossRefPubMed

Traister A, Shi W, Filmus J (2008) Mammalian Notum induces the release of glypicans and other GPI-anchored proteins from the cell surface. Biochem J 410:503–511. https://doi.org/10.1042/BJ20070511 CrossRefPubMed

Tsuda M et al (1999) The cell-surface proteoglycan Dally regulates Wingless signalling in Drosophila. Nature 400:276–280CrossRefPubMed

Urtreger A, Ladeda V, Puricelli L, Rivelli A, Vidal MC, Lustig ES, Bal de Kier Joffé E (1997) Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two murine mammary cell lines. Int J Oncol 11:489–496PubMed

Valsechi MC et al (2014) GPC3 reduces cell proliferation in renal carcinoma cell lines. BMC Cancer 14:631. https://doi.org/10.1186/1471-2407-14-631 CrossRefPubMedPubMedCentral

Veugelers M et al (1999) Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J Biol Chem 274:26968–26977CrossRefPubMed

Xu Y, Li N, Xiang R, Sun P (2014) Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends Biochem Sci 39:268–276. https://doi.org/10.1016/j.tibs.2014.04.004 CrossRefPubMedPubMedCentral

Xu J, Lv W, Hu Y, Wang L, Wang Y, Cao J, Hu J (2017) Wnt3a expression is associated with epithelial-mesenchymal transition and impacts prognosis of lung adenocarcinoma. Patients J Cancer 8:2523–2531. https://doi.org/10.7150/jca.18560 CrossRefPubMed

Yan D, Wu Y, Feng Y, Lin SC, Lin X (2009) The core protein of glypican Dally-like determines its biphasic activity in wingless morphogen signaling. Dev Cell 17:470–481. https://doi.org/10.1016/j.devcel.2009.09.001 CrossRefPubMedPubMedCentral

Zittermann SI, Capurro MI, Shi W, Filmus J (2010) Soluble glypican 3 inhibits the growth of hepatocellular carcinoma in vitro and in vivo. Int J Cancer 126:1291–1301. https://doi.org/10.1002/ijc.24941 CrossRefPubMed

Zuluaga S, Alvarez-Barrientos A, Gutierrez-Uzquiza A, Benito M, Nebreda AR, Porras A (2007) Negative regulation of Akt activity by p38alpha MAP kinase in cardiomyocytes involves membrane localization of PP2A through interaction with caveolin-1. Cell Signal 19:62–74. https://doi.org/10.1016/j.cellsig.2006.05.032 CrossRefPubMed

Titel: Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway
verfasst von: Dolores Fernández
Macarena Guereño
María Amparo Lago Huvelle
Magalí Cercato
María Giselle Peters
Publikationsdatum: 28.09.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 12/2018
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-018-2751-0

Neu im Fachgebiet Onkologie

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Springer Medizin

Signaling network involved in the GPC3-induced inhibition of breast cancer progression: role of canonical Wnt pathway